Randomized Double-blind Controlled Trial of Use of Dydrogesterone in Threatened Miscarriage
Status:
Completed
Trial end date:
2018-05-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine whether the dydrogesterone therapy is associated with
reduction in miscarriage in women with first trimester threatened miscarriage. The hypothesis
is that the dydrogesterone therapy will significantly reduce the risk of miscarriage in women
with threatened miscarriage.